Portfolio Lab

QuidelOrtho Corp

  • Stock
  • Ticker QDEL
  • ISIN US2197981051
  • Nasdaq

Health care · Diagnostics · USA

$8.32 −6.73%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of QuidelOrtho Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

QDELGlobal equities (VT)

$10,000 grew to $3,619. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −97.2% in 11/2026, measured from the peak in 08/2020. The old peak has not been reached again yet.

1-year return
−61.0%
5-year return p.a.
−44.1%
10-year return p.a.
−9.7%
Volatility p.a.
55.5%
Largest decline
−97.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue708693614700724620631619
Operating income-10033-181-705-66-32-22-7.5
EBITDA8.9140-70-593468195112
Net income-178-13-255-733-131-92-93-54
Earnings per share-2.62-0.19-3.77-10.78-1.90-1.35-1.36-0.78
Balance sheet
Total assets6,4246,4626,3795,6755,7695,6295,7155,781
Liabilities3,4393,4643,5863,6393,8493,7773,9403,990
Equity2,9852,9972,7932,0361,9211,8511,7751,791
Cash9812715298170140123166
Long-term debt2,489–––2,698–––
Cash flow
Operating cash flow6466-47-46132-33-11120
Capital expenditure-47-56-38-50-45-34-26-21
Free cash flow179.4-84-9687-67-136-1.4

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2020 at +139.4%, weakest 2024 at −39.6%. 4 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026−$0.78
7 Aug 2026−$1.36
6 May 2026−$1.35
19 Feb 2026−$1.90
6 Nov 2025−$10.78
6 Aug 2025−$3.77
8 May 2025−$0.19
27 Feb 2025−$2.62
8 Nov 2024−$0.30
1 Aug 2024−$2.20
9 May 2024−$25.50
29 Feb 2024$0.11

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€517m
Market cap in trading currency
$571m
Enterprise value
$829m
P/E
–
P/S
0.22
P/B
0.32
EV/Sales
0.32
EV/EBITDA
2.5
Earnings yield
–
FCF yield
-20.5%

Results (last four quarters)

Revenue
$2.59bn
Gross profit
–
EBITDA
$334m
Net income
−$369m
Earnings per share
−$5.39
Revenue per share
$37.79
Revenue growth
−11.6%
Earnings growth
–

Profitability

Gross margin
–
Operating margin
-4.9%
Net margin
-14.2%
Return on equity
-19.3%
Return on assets
-6.4%

Balance sheet and cash flow

Cash
$166m
Cash per share
$2.43
Financial debt
$424m
Debt/equity %
24
Current ratio
1.36
Book value per share
$26.11
Operating cash flow
$7.90m
Free cash flow
−$117m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
68.6m
Volume
2.61m
Avg. volume 3 months
1.92m
Relative volume
1.3

Price and technicals

Price
$8.32
1 day
−6.7%
52-week high
$35.38
52-week low
$8.32
Distance to 52-week high
−76.5%
Distance to 52-week low
0.0%
Distance to 50-day line
−30.5%
Distance to 200-day line
−44.2%
RSI (14)
29
Volatility 1M
105.0%

Performance

1 week
−22.5%
1 month
−38.3%
3 months
−42.6%
6 months
−29.8%
YTD
−70.9%
1 year
−60.4%

Dates

Fiscal year end
28 Dec 2025
Most recent quarter
27 Sep 2026

Frequently asked questions

How has QDEL performed since 11/2016?

$10,000 grew to $3,619 by 20 Nov 2026, which is −9.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is QDEL?

Volatility was 55.5% per year, measured on monthly returns. The largest decline from a peak was −97.2%, with the low in 11/2026.

How does QDEL compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, QDEL returned −9.7% at 55.5%. The correlation of monthly returns was 0.13; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

QuidelOrtho Corp (QDEL): Return and risk | Portfolio Lab